Centre Jean Perrin

The medical center is at the forefront of research in urothelial cancer, focusing on innovative treatments for metastatic or locally advanced unresectable urothelial cancer. The center's research aims to improve overall survival rates through novel therapeutic approaches.

• Metastatic Urothelial Cancer
• Advanced Unresectable Urothelial Cancer

By exploring new treatment paradigms, the center contributes significantly to the understanding and management of this challenging condition.

Specializing in breast cancer, the center conducts extensive research on ER-positive, HER2-negative breast cancer, particularly in patients with genetic mutations. The focus is on enhancing progression-free survival through targeted therapies.

• ER-positive, HER2-negative Breast Cancer
• BRCA Gene Mutations

The center's work in this area is pivotal in developing personalized treatment strategies for breast cancer patients.

The center is pioneering research in the field of migraines with aura, investigating the efficacy of novel prophylactic treatments. This research aims to provide new insights into migraine management and prevention.

• Migraine Aura Prophylaxis

Through innovative studies, the center is enhancing the understanding of migraine pathophysiology and treatment.

Focusing on prostate cancer, the center is involved in cutting-edge research for castration-resistant prostate cancer and hormone-sensitive prostate cancer. The goal is to improve survival outcomes through advanced therapeutic strategies.

• Castration-Resistant Prostate Cancer
• Hormone-Sensitive Prostate Cancer

The center's research is instrumental in developing new treatment protocols for prostate cancer patients.

The center is advancing research in endometrial and ovarian cancer, focusing on innovative treatment combinations to improve patient outcomes. This includes exploring the efficacy of novel drug combinations in recurrent cases.

• Metastatic Endometrial Cancer
• Ovarian Carcinosarcoma

Through its research, the center is contributing to the development of more effective therapies for these cancers.

Specializing in thyroid cancer, the center is conducting research on RET-mutant medullary thyroid cancer. The focus is on comparing the efficacy of different kinase inhibitors to improve progression-free survival.

• RET-Mutant Medullary Thyroid Cancer

The center's research efforts are crucial in advancing treatment options for thyroid cancer patients.

The center is at the forefront of research in neuroendocrine tumors, particularly those of gastroenteric or pancreatic origin. The focus is on improving progression-free survival through targeted radioligand therapies.

• Gastroenteric Neuroendocrine Tumors
• Pancreatic Neuroendocrine Tumors

By exploring new therapeutic avenues, the center is enhancing the management of neuroendocrine tumors.

The center is engaged in research on soft tissue sarcoma, focusing on improving metastasis-free survival through innovative chemotherapy regimens. This research is vital for patients with high-risk sarcomas.

• High-Risk Soft Tissue Sarcoma

The center's work is pivotal in developing new treatment strategies for sarcoma patients.

Specializing in lung cancer, the center is conducting research on non-small cell lung cancer and small cell lung cancer. The focus is on improving survival outcomes through novel immunotherapy and chemotherapy combinations.

• Non-Small Cell Lung Cancer
• Small Cell Lung Cancer

The center's research is instrumental in advancing treatment options for lung cancer patients.